Comparison of media milling and microfluidization methods for engineering of nanocrystals: a case study

References

• Merisko-Liversidge E. Nanocrystals: resolving pharmaceutical formulation issues associated with poorly water-soluble compounds. Particles. Orlando: Marcel Dekker; 2002.
   Google Scholar
• Speiser PP. Poorly soluble drugs, a challenge in drug delivery. Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Stuttgart: Medpharm Scientific Publishers; 1998.
   Google Scholar
• Willems L, Van der Geest R, De Beule K. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics. J Clin Pharm Ther. 2001;26(3):159–169.
   PubMed Web of Science ®Google Scholar
• Junghanns JU, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine. 2008;3(3):295–309.
   PubMed Web of Science ®Google Scholar
• Mahesh KV, Singh SK, Gulati M. A comparative study of top-down and bottom-up approaches for the preparation of nanosuspensions of glipizide. Powder Technol. 2014;256:436–449.
   Web of Science ®Google Scholar
• Bilati U, Allémann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci. 2005;24(1):67–75.
   PubMed Web of Science ®Google Scholar
• Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3(9):785–796.
   PubMed Web of Science ®Google Scholar
• Date AA, Patravale VB. Current strategies for engineering drug nanoparticles. Curr Opin Colloid Interface Sci. 2004;9(3–4):222–235.
   Web of Science ®Google Scholar
• Singare DS, Marella S, Gowthamrajan K, et al. Optimization of formulation and process variable of nanosuspension: an industrial perspective. Int J Pharm. 2010;402(1–2):213–220.
   PubMed Web of Science ®Google Scholar
• Malamatari M, Taylor KM, Malamataris S, et al. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discov Today. 2018;23(3):534–547.
   PubMed Web of Science ®Google Scholar
• Bruno RP, McIlwrick R. Microfluidizer processor technology for high performance particle size reduction, mixing and dispersion. Eur J Pharm Biopharm. 1999;56:29–36.
   Google Scholar
• Tunick MH, Van Hekken DL, Cooke PH, et al. Transmission electron microscopy of mozzarella cheeses made from microfluidized milk. J Agric Food Chem. 2002;50(1):99–103.
   PubMed Web of Science ®Google Scholar
• Microfluidics™ [Internet]. Microfluidizer® interaction chambers; [cited 2020 Jul 16]; Available from: https://www.microfluidics-mpt.com/microfluidizer-interaction-chambers
   Google Scholar
• Wehrli W. Rifampin: mechanisms of action and resistance. Rev Infect Dis. 1983;5(3):407–411.
   Google Scholar
• Zhao M, You Y, Ren Y, et al. Formulation, characteristics and aerosolization performance of azithromycin DPI prepared by spray-drying. Powder Technol. 2008;187(3):214–221.
   Web of Science ®Google Scholar
• LaMont SP, LaBone TR, Cadieux JR, et al. In vitro lung dissolutions rates for PuO2. J Radioanal Nucl Chem. 2006;269(2):271–277.
   Web of Science ®Google Scholar
• Dressman JB, Krämer J. Pharmaceutical dissolution testing. Boca Raton: Taylor & Francis; 2005.
   Google Scholar
• Gite S, Chogale M, Patravale V. Development and validation of a discriminating dissolution method for atorvastatin delayed-release nanoparticles using a flow-through cell: a comparative study using USP apparatus 4 and 1. Dissolution Technol. 2016;23(2):14–20.
   Web of Science ®Google Scholar
• Martena V, Shegokar R, Di Martino P, et al. Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals. Drug Dev Ind Pharm. 2014;40(9):1199–1205.
   PubMed Web of Science ®Google Scholar
• Verma S, Gokhale R, Burgess DJ. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm. 2009;380(1–2):216–222.
   PubMed Web of Science ®Google Scholar
• Cerdeira AM, Mazzotti M, Gander B. Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability. Int J Pharm. 2010;396(1–2):210–218.
   PubMedGoogle Scholar
• Alshora DH, Ibrahim MA, Alanazi FK. Chapter 6. Nanotechnology from particle size reduction to enhancing aqueous solubility. In: Grumezescu AM, editor. Surface chemistry of nanobiomaterials. Norwich (NY): William Andrew Publishing; 2016. p. 163–191.
   Google Scholar
• Ghosh I, Schenck D, Bose S, et al. Identification of critical process parameters and its interplay with nanosuspension formulation prepared by top down media milling technology—a QbD perspective. Pharm Dev Technol. 2013;18(3):719–729.
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Marwah A, Pillai R. Media milling process optimization for manufacture of drug nanoparticles using design of experiments (DOE). Drug Dev Ind Pharm. 2015;41(1):124–130.
   PubMed Web of Science ®Google Scholar
• Kumar S, Gokhale R, Burgess DJ. Quality by design approach to spray drying processing of crystalline nanosuspensions. Int J Pharm. 2014;464(1–2):234–242.
   PubMedGoogle Scholar
• Karakucuk A, Celebi N, Teksin ZS. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of experiment approach. Eur J Pharm Sci. 2016;95:111–121.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Ashokraj Y, Bharatam PV, et al. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci. 2004;22(2–3):127–144.
   PubMed Web of Science ®Google Scholar
• Pelizza G, Nebuloni M, Ferrari P, et al. Polymorphism of rifampicin. Farmaco Sci. 1977;32(7):471–481.
   PubMedGoogle Scholar
• Kalvakuntla S, Deshpande M, Attari Z, et al. Preparation and characterization of nanosuspension of aprepitant by H96 process. Adv Pharm Bull. 2016;6(1):83–90.
   PubMed Web of Science ®Google Scholar
• Henwood SQ, De Villiers MM, Liebenberg W, et al. Solubility and dissolution properties of generic rifampicin raw materials. Drug Dev Ind Pharm. 2000;26(4):403–408.
   PubMed Web of Science ®Google Scholar
• Issa MG, Ferraz HG. Intrinsic dissolution as a tool for evaluating drug solubility in accordance with the biopharmaceutics classification system. Dissolution Technol. 2011;18(3):6–11.
   Web of Science ®Google Scholar